Stephen Dow has resigned as director of Alder Biopharmaceuticals Inc., effective May 24.
Dow did not express any disagreement on any matter relating to the company's operations, policies or practices, Alder Biopharmaceuticals stated in a Form 8-K filing.
Bothell, Wash.-based Alder Biopharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes therapeutic antibodies in the U.S., Australia and Ireland.
